{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T17:05:52Z","timestamp":1776704752840,"version":"3.51.2"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T00:00:00Z","timestamp":1659225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T00:00:00Z","timestamp":1659225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Targeted temperature management at 33\u00a0\u00b0C (TTM33) has been employed in effort to mitigate brain injury in unconscious survivors of out-of-hospital cardiac arrest (OHCA). Current guidelines recommend prevention of fever, not excluding TTM33. The main objective of this study was to investigate if TTM33 is associated with mortality in patients with vasopressor support on admission after OHCA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We performed a post hoc analysis of patients included in the TTM-2 trial, an international, multicenter trial, investigating outcomes in unconscious adult OHCA patients randomized to TTM33 versus normothermia. Patients were grouped according to level of circulatory support on admission: (1) no-vasopressor support, mean arterial blood pressure (MAP)\u2009\u2265\u200970\u00a0mmHg; (2) moderate-vasopressor support MAP\u2009&lt;\u200970\u00a0mmHg or any dose of dopamine\/dobutamine or noradrenaline\/adrenaline dose\u2009\u2264\u20090.25\u00a0\u00b5g\/kg\/min; and (3) high-vasopressor support, noradrenaline\/adrenaline dose\u2009&gt;\u20090.25\u00a0\u00b5g\/kg\/min. Hazard ratios with TTM33 were calculated for all-cause 180-day mortality in these groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The TTM-2 trial enrolled 1900 patients. Data on primary outcome were available for 1850 patients, with 662, 896, and 292 patients in the, no-, moderate-, or high-vasopressor support groups, respectively. Hazard ratio for 180-day mortality was 1.04 [98.3% CI 0.78\u20131.39] in the no-, 1.22 [98.3% CI 0.97\u20131.53] in the moderate-, and 0.97 [98.3% CI 0.68\u20131.38] in the high-vasopressor support groups with regard to TTM33. Results were consistent in an imputed, adjusted sensitivity analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In this exploratory analysis, temperature control at 33\u00a0\u00b0C after OHCA, compared to normothermia, was not associated with higher incidence of death in patients stratified according to vasopressor support on admission.<\/jats:p><jats:p><jats:italic>Trial registration<\/jats:italic>Clinical trials identifier<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02908308\">NCT02908308<\/jats:ext-link>, registered September 20, 2016.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13054-022-04107-9","type":"journal-article","created":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T07:03:27Z","timestamp":1659251007000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Influence of temperature management at 33\u00a0\u00b0C versus normothermia on survival in patients with vasopressor support after out-of-hospital cardiac arrest: a post hoc analysis of the TTM-2 trial"],"prefix":"10.1186","volume":"26","author":[{"given":"Joachim","family":"D\u00fcring","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Annborn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Cariou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle S.","family":"Chew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"Dankiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Friberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Haenggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zana","family":"Haxhija","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janus C.","family":"Jakobsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Halvor","family":"Langeland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio Silvio","family":"Taccone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susann","family":"Ull\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matt P.","family":"Wise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niklas","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,31]]},"reference":[{"issue":"1","key":"4107_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40635-019-0291-9","volume":"8","author":"H Olai","year":"2020","unstructured":"Olai H, Thorneus G, Watson H, Macleod M, Rhodes J, Friberg H, Nielsen N, Cronberg T, Deierborg T. Meta-analysis of targeted temperature management in animal models of cardiac arrest. Intensive Care Med Exp. 2020;8(1):3.","journal-title":"Intensive Care Med Exp"},{"issue":"8","key":"4107_CR2","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1056\/NEJMoa003289","volume":"346","author":"SA Bernard","year":"2002","unstructured":"Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, Smith K. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med. 2002;346(8):557\u201363.","journal-title":"N Engl J Med"},{"issue":"8","key":"4107_CR3","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1056\/NEJMoa012689","volume":"346","author":"Hypothermia after Cardiac Arrest Study G","year":"2002","unstructured":"Hypothermia after Cardiac Arrest Study G. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002;346(8):549\u201356.","journal-title":"N Engl J Med"},{"issue":"23","key":"4107_CR4","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1056\/NEJMoa1310519","volume":"369","author":"N Nielsen","year":"2013","unstructured":"Nielsen N, Wetterslev J, Cronberg T, Erlinge D, Gasche Y, Hassager C, Horn J, Hovdenes J, Kjaergaard J, Kuiper M, et al. Targeted temperature management at 33 degrees C versus 36 \u00b0C after cardiac arrest. N Engl J Med. 2013;369(23):2197\u2013206.","journal-title":"N Engl J Med"},{"issue":"24","key":"4107_CR5","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1056\/NEJMoa2100591","volume":"384","author":"J Dankiewicz","year":"2021","unstructured":"Dankiewicz J, Cronberg T, Lilja G, Jakobsen JC, Levin H, Ull\u00e9n S, Rylander C, Wise MP, Oddo M, Cariou A, et al. Hypothermia versus normothermia after out-of-hospital cardiac arrest. N Engl J Med. 2021;384(24):2283\u201394.","journal-title":"N Engl J Med"},{"key":"4107_CR6","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00134-022-06620-5","volume":"48","author":"C Sandroni","year":"2022","unstructured":"Sandroni C, Nolan JP, Andersen LW, Bottiger BW, Cariou A, Cronberg T, Friberg H, Genbrugge C, Lilja G, Morley PT, et al. ERC-ESICM guidelines on temperature control after cardiac arrest in adults. Intensive Care Med. 2022;48:261\u20139.","journal-title":"Intensive Care Med"},{"issue":"5","key":"4107_CR7","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1161\/CIRCINTERVENTIONS.114.001556","volume":"7","author":"J Bro-Jeppesen","year":"2014","unstructured":"Bro-Jeppesen J, Hassager C, Wanscher M, Ostergaard M, Nielsen N, Erlinge D, Friberg H, Kober L, Kjaergaard J. Targeted temperature management at 33 \u00b0C versus 36 \u00b0C and impact on systemic vascular resistance and myocardial function after out-of-hospital cardiac arrest: a sub-study of the Target Temperature Management Trial. Circ Cardiovasc Interv. 2014;7(5):663\u201372.","journal-title":"Circ Cardiovasc Interv"},{"issue":"9","key":"4107_CR8","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1007\/s00134-014-3375-8","volume":"40","author":"M Annborn","year":"2014","unstructured":"Annborn M, Bro-Jeppesen J, Nielsen N, Ullen S, Kjaergaard J, Hassager C, Wanscher M, Hovdenes J, Pellis T, Pelosi P, et al. The association of targeted temperature management at 33 and 36 \u00b0C with outcome in patients with moderate shock on admission after out-of-hospital cardiac arrest: a post hoc analysis of the Target Temperature Management trial. Intensive Care Med. 2014;40(9):1210\u20139.","journal-title":"Intensive Care Med"},{"key":"4107_CR9","doi-asserted-by":"publisher","first-page":"A80","DOI":"10.1016\/j.resuscitation.2020.09.012","volume":"156","author":"J Soar","year":"2020","unstructured":"Soar J, Berg KM, Andersen LW, B\u00f6ttiger BW, Cacciola S, Callaway CW, Couper K, Cronberg T, D\u2019Arrigo S, Deakin CD, et al. Adult advanced life support: 2020 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Resuscitation. 2020;156:A80\u2013119.","journal-title":"Resuscitation"},{"key":"4107_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ahj.2019.06.012","volume":"217","author":"J Dankiewicz","year":"2019","unstructured":"Dankiewicz J, Cronberg T, Lilja G, Jakobsen JC, Belohlavek J, Callaway C, Cariou A, Eastwood G, Erlinge D, Hovdenes J, et al. Targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest (TTM2): a randomized clinical trial-rationale and design. Am Heart J. 2019;217:23\u201331.","journal-title":"Am Heart J"},{"issue":"1","key":"4107_CR11","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1186\/s13063-020-04654-y","volume":"21","author":"JC Jakobsen","year":"2020","unstructured":"Jakobsen JC, Dankiewicz J, Lange T, Cronberg T, Lilja G, Levin H, Belohlavek J, Callaway C, Cariou A, Erlinge D, et al. Targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest: a statistical analysis plan. Trials. 2020;21(1):831.","journal-title":"Trials"},{"issue":"7","key":"4107_CR12","doi-asserted-by":"publisher","first-page":"e208215","DOI":"10.1001\/jamanetworkopen.2020.8215","volume":"3","author":"CW Callaway","year":"2020","unstructured":"Callaway CW, Coppler PJ, Faro J, Puyana JS, Solanki P, Dezfulian C, Doshi AA, Elmer J, Frisch A, Guyette FX, et al. Association of initial illness severity and outcomes after cardiac arrest with targeted temperature management at 36 \u00b0C or 33 \u00b0C. JAMA Netw Open. 2020;3(7):e208215.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"4107_CR13","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13613-019-0603-y","volume":"9","author":"T Okazaki","year":"2019","unstructured":"Okazaki T, Hifumi T, Kawakita K, Kuroda Y, Japanese Association for Acute Medicine Out-of-Hospital Cardiac Arrest R. Targeted temperature management guided by the severity of hyperlactatemia for out-of-hospital cardiac arrest patients: a post hoc analysis of a nationwide, multicenter prospective registry. Ann Intensive Care. 2019;9(1):127.","journal-title":"Ann Intensive Care"},{"issue":"8","key":"4107_CR14","doi-asserted-by":"crossref","first-page":"e741","DOI":"10.1097\/CCM.0000000000005025","volume":"49","author":"M Nishikimi","year":"2021","unstructured":"Nishikimi M, Ogura T, Nishida K, Hayashida K, Emoto R, Matsui S, Matsuda N, Iwami T. Outcome related to level of targeted temperature management in postcardiac arrest syndrome of low, moderate, and high severities: a nationwide multicenter prospective registry. Crit Care Med. 2021;49(8):e741\u201350.","journal-title":"Crit Care Med"},{"issue":"24","key":"4107_CR15","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1056\/NEJMoa1906661","volume":"381","author":"JB Lascarrou","year":"2019","unstructured":"Lascarrou JB, Merdji H, Le Gouge A, Colin G, Grillet G, Girardie P, Coupez E, Dequin PF, Cariou A, Boulain T, et al. Targeted temperature management for cardiac arrest with nonshockable rhythm. N Engl J Med. 2019;381(24):2327\u201337.","journal-title":"N Engl J Med"},{"issue":"3","key":"4107_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1177\/0885066618817518","volume":"35","author":"C Jou","year":"2020","unstructured":"Jou C, Shah R, Figueroa A, Patel JK. The role of inflammatory cytokines in cardiac arrest. J Intensive Care Med. 2020;35(3):219\u201324.","journal-title":"J Intensive Care Med"},{"key":"4107_CR17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.resuscitation.2019.01.031","volume":"136","author":"L Witten","year":"2019","unstructured":"Witten L, Gardner R, Holmberg MJ, Wiberg S, Moskowitz A, Mehta S, Grossestreuer AV, Yankama T, Donnino MW, Berg KM. Reasons for death in patients successfully resuscitated from out-of-hospital and in-hospital cardiac arrest. Resuscitation. 2019;136:93\u20139.","journal-title":"Resuscitation"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-022-04107-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-022-04107-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-022-04107-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T05:01:09Z","timestamp":1700888469000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-022-04107-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,31]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["4107"],"URL":"https:\/\/doi.org\/10.1186\/s13054-022-04107-9","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,31]]},"assertion":[{"value":"21 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The TTM trial protocol was approved by ethical committees in each participating country, and informed consent was waived or obtained from all participants or relatives according to national legislations, in line with the Helsinki declaration, Ethical Review Board approval, REPN Lund DNR 2015\/228.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JD: No financial or non-financial competing interests. MA: No financial or non-financial competing interests. AC: Received fees for lectures from Bard. MC: No financial or non-financial competing interests. JD: No financial or non-financial competing interests. HF: TEQCool (Lund, Sweden) Academic advisor. MH: No financial or non-financial competing interests. ZH: No financial or non-financial competing interests. JCJ: No financial or non-financial competing interests. HL: No financial or non-financial competing interests. FT: No financial or non-financial competing interests. MT: No financial competing interests, co-applicant on several NIHR cardiac arrest trials but not in the field of temperature management. SU: No financial or non-financial competing interests. MPW: No financial or non-financial competing interests. NN: No financial or non-financial competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"231"}}